García Urquiza, IruneMartínez, ÓscarLópez Paz, Juan FranciscoGarcía Martín, MaitaneEspinosa Blanco, PatriciaRodríguez Bermejo, Alicia AuroraPallarès-Sastre, MercèRuiz de Lazcano Sánchez, AitanaAmayra Caro, Imanol2024-11-192024-11-192024García, I., Martínez, O., López-Paz, J. F., García, M., Espinosa-Blanco, P., Rodríguez, A. A., Pallarès-Sastre, M., Ruiz de Lazcano, A., & Amayra, I. (2024). Social cognition in DMD and BMD dystrophinopathies: A cross-sectional preliminary study. Clinical Neuropsychologist, 38(1), 219-234. https://doi.org/10.1080/13854046.2023.220233210.1080/13854046.2023.2202332http://hdl.handle.net/20.500.14454/1982Objective: The dystrophinopathies called Duchenne and Becker muscular dystrophies (DMD/BMD) are rare, progressive, incurable, and life-limiting paediatric-onset neuromuscular diseases. These diseases have long been associated with specific neuropsychological deficits. However, the performance of these patients in the social cognition domain has not been properly investigated. Thus, the main objective of this study was to compare the performance on social cognition between DMD/BMD patients and healthy age-matched boys. Method: This cross-sectional study included 20 DMD/BMD children and adolescents and 20 healthy controls. The protocol included the Social Perception Domain of the NEPSY-II, the Reading the Mind in the Eyes Test–Child and Happé’s Strange Stories test. General intelligence was controlled to eliminate the possible influence of covariables. All the assessments were performed remotely. Results: Most social cognition tasks were worse in patients with DMD/BMD than in matched healthy controls. These differences remained even after controlling for the general intelligence variable, with the exception of Total Disgust Errors (F = 1.462, p =.234, η2p=.038) and Verbal task (F = 1.820, p =.185, η2p=.047) scores from the NEPSY-II. Conclusions: This is the first study to demonstrate that the neuropsychological domain of social cognition is impaired in DMD/BMD patients, independent of the level of general intelligence. Screening assessments in DMD/BMD patients should be promoted to allow social cognition difficulties to be detected at an early stage to enhance patients’ quality of life and social development.eng© 2023 Informa UK Limited, trading as Taylor & Francis GroupBMDDMDDystrophinopathiesGeneral intelligenceSocial cognitionjournal article2024-11-191744-4144